reactions to tirzepatide Does cause dermatologic adverse effects, such as injection‑site or hypersensitivity skin eruptions? Tirzepatide Tips for Zepbound Site

Semaglutide therapy is typically not recommended for people who are pregnant or breastfeeding, are allergic to semaglutide, or have certain health conditions, including pancreatitis, severe gastrointestinal disease, or severe kidney disease

When combined with Semaglutide or Tirzepatide, BPC 157 can help to mitigate some of the gastrointestinal side effects and enhance overall treatment outcomes

For instance, pancreatic beta cells depend on factors such as NF- and Wnt/-catenin to enhance cellular proliferation and differentiation (Kroon et al

Overall, more research is needed to establish clear guidelines and to ensure both maternal and fetal safety when considering GLP-1 therapies in the context of pregnancy